Position in SVRA
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$746,928
+$408,576 QoQ
Shares Held
136,800
-7.8% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 184 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swiss National Bank holds $1,641,068,486 across 148 Biotechnology names. SVRA ranks #142 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,600 | $332,493,684 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
303,140 | $234,218,089 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
387,720 | $128,284,916 | |
| 4 | INSM |
INSMED Inc
|
625,912 | $102,349,130 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,191,100 | $57,137,067 | |
| 6 | INCY |
Incyte Corp
|
489,774 | $46,097,528 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
425,431 | $41,373,164 | |
| 8 | MRNA |
Moderna, Inc.
|
696,100 | $35,361,880 |
All Filings in SVRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $746,928 | 136,800 | Shares | Sole | 2026-05-07 | |
| 2025-06-30 | $338,352 | 148,400 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $493,060 | 178,000 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $546,460 | 178,000 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $808,992 | 190,800 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $592,410 | 147,000 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $732,060 | 147,000 | Shares | Sole | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||